These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion. Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A. J Allergy Clin Immunol; 2001 May; 107(5):818-23. PubMed ID: 11344348 [Abstract] [Full Text] [Related]
3. No association between the deltaF508 cystic fibrosis mutation and type 2 diabetes mellitus. Braun J, Arnemann J, Lohrey M, Donner H, Siegmund T, Usadel KH, Badenhoop K. Exp Clin Endocrinol Diabetes; 1999 May; 107(8):568-9. PubMed ID: 10612489 [Abstract] [Full Text] [Related]
4. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis]. Iwańczak F, Smigiel R, Stawarski A, Pawłowicz J, Stembalska A, Mowszet K, Sasiadek M. Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132 [Abstract] [Full Text] [Related]
6. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France. Duguépéroux I, De Braekeleer M, Participating Centres to the French National Cystic Fibrosis Registry. J Cyst Fibros; 2004 Dec; 3(4):259-63. PubMed ID: 15698945 [Abstract] [Full Text] [Related]
7. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels. Massie RJ, Wilcken B, Van Asperen P, Dorney S, Gruca M, Wiley V, Gaskin K. J Pediatr; 2000 Aug; 137(2):214-20. PubMed ID: 10931414 [Abstract] [Full Text] [Related]
8. Glucose homeostasis and genotype-phenotype interplay in cystic fibrosis patients with CFTR gene deltaF508 mutation. Preumont V, Hermans MP, Lebecque P, Buysschaert M. Diabetes Care; 2007 May; 30(5):1187-92. PubMed ID: 17337503 [Abstract] [Full Text] [Related]
9. Population screening of F508del (DeltaF508), the most frequent mutation in the CFTR gene associated with cystic fibrosis in Argentina. Roqué M, Godoy CP, Castellanos M, Pusiol E, Mayorga LS. Hum Mutat; 2001 Aug; 18(2):167. PubMed ID: 11462248 [Abstract] [Full Text] [Related]
10. Frequency and clinical significance of the S1235R mutation in the cystic fibrosis transmembrane conductance regulator gene: results from a collaborative study. Monaghan KG, Feldman GL, Barbarotto GM, Manji S, Desai TK, Snow K. Am J Med Genet; 2000 Dec 11; 95(4):361-5. PubMed ID: 11186891 [Abstract] [Full Text] [Related]
12. [Frequency of delta F508 mutation in Venezuelan patients with cystic fibrosis]. Morales-Machin A, Borjas-Fajardo L, Pineda L, González S, Delgado W, Zabala W, Fernández E. Invest Clin; 2004 Jun 11; 45(2):121-30. PubMed ID: 15211979 [Abstract] [Full Text] [Related]
13. Cystic fibrosis heterozygotes do not have increased platelet activation. Tarnow I, Michelson AD, Frelinger AL, Linden MD, Li Y, Fox ML, Barnard MR, O'Sullivan BP. Thromb Res; 2007 Jun 11; 121(2):159-62. PubMed ID: 17532368 [Abstract] [Full Text] [Related]